Vitamin A and their derivatives remain one of the most studied classes of topical actives in dermatology. Their role in improving fine lines, uneven pigmentation, and dermal matrix integrity is well established. Yet in the real world, outcomes vary widely.
Irritation, barrier disruption, and inconsistent tolerance are common, particularly outside of controlled clinical settings.
This discrepancy is less about efficacy, and more about how retinoids interact with skin as a biological system.
Mechanism: Receptor Binding and Cellular Turnover
Retinoids exert their effects through binding to nuclear receptors, influencing gene expression involved in keratinocyte proliferation, differentiation, and collagen synthesis.
This leads to:
⟢ Increased epidermal turnover
⟢ Reduced cohesiveness of corneocytes
⟢ Upregulation of dermal collagen production
⟢ Modulation of melanocyte activity
They place metabolic demand on the skin and require functional barrier integrity to proceed without adverse effects.
Concentration vs. Conversion
The assumption that higher-strength retinoids yield better outcomes does not account for conversion pathways.
Retinoic acid is the biologically active form. Cosmetic retinoids such as retinol and retinyl esters must undergo enzymatic conversion within the skin:
Retinyl ester → Retinol → Retinaldehyde → Retinoic acid
Each step reduces the rate at which active retinoic acid is formed. Retinyl palmitate, in particular, sits at the start of this pathway. Its activity depends on the skin’s enzymatic capacity, resulting in slower, lower-level signalling.
This has two implications:
⟢ Reduced irritation potential due to gradual activation
⟢ Lower peak efficacy compared to direct retinoic acid
In compromised or sensitive skin, slower conversion can improve overall tolerability and adherence, which in turn influences long-term outcomes.
Barrier Function as a Limiting Factor
Retinoid-induced irritation is often framed as an expected adjustment phase. However, it is more accurately understood as a disruption of barrier homeostasis.
Increased turnover and reduced corneocyte cohesion transiently weaken the stratum corneum. This increases transepidermal water loss and allows deeper penetration of actives, including the retinoid itself.
When barrier recovery does not keep pace with retinoid signalling, cumulative irritation occurs.
Clinically, this presents as:
⟢ Persistent redness
⟢ Scaling beyond initial adaptation
⟢ Increased sensitivity to other products
⟢ Reduced tolerance over time
Managing retinoid use therefore requires concurrent support of barrier repair mechanisms.
Topical Retinoids and Pregnancy
Systemic retinoids are contraindicated in pregnancy due to established teratogenicity. For topical retinoids, systemic absorption is minimal, particularly with cosmetic derivatives such as retinyl esters.
Retinyl palmitate, as a preformed and slower-converting vitamin A derivative, operates at a significantly lower biological activity compared to prescription retinoids. Its conversion to active retinoic acid is indirect and regulated by the skin.
Retinoids in the Context of Ageing
Ageing skin demonstrates reduced lipid production, slower repair kinetics, and increased sensitivity to external stimuli. These changes alter how retinoids are tolerated.
While retinoids can improve markers of ageing, excessive or poorly integrated use can induce chronic low-grade inflammation, which itself contributes to collagen degradation.
This creates a paradox where overuse undermines the intended outcome.
Clinical Use: Integration Over Escalation
Effective retinoid use is not defined by maximal strength, but by sustained tolerability.
In practice:
⟢ Initiation at lower concentrations or slower-converting derivatives
⟢ Gradual increase in frequency based on tolerance
⟢ Concurrent use of barrier-supportive formulations
⟢ Avoidance of overlapping irritants during early phases
Consistency at a tolerable level produces more reliable outcomes than intermittent high-intensity use.
Where This Sits Within Zyu
Retinyl palmitate is used within the Antioxidant Night Mask as part of a broader formulation designed to support overnight repair without overwhelming the skin.
Rather than positioning vitamin A as a high-intensity corrective, the formulation pairs retinyl palmitate with barrier-supportive and antioxidant components to maintain skin stability while encouraging gradual renewal.
In practice, this means:
⟢ A lower-signal approach to vitamin A activity
⟢ Reduced likelihood of irritation compared to more direct retinoids
⟢ Compatibility with skin that prioritises repair over aggressive turnover
The Zyu Perspective
At Zyu, retinoids are approached as modulators of skin function rather than standalone corrective agents. Their benefits are dependent on the environment in which they are used.Formulation and routine design prioritise controlled signalling, barrier stability, and long-term adherence.
Because in ageing skin, the objective is not acceleration, but regulation.
